María Merino

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei et al. · JAMA · 1995 · 605 citations

Medicine, Endocrinology, Pharmacology +15

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor

James R. Vasselli, Joanna H. Shih, Shuba R. Iyengar et al. · Proceedings of the National Academy of Sciences · 2003 · 175 citations · Full text

Medicine, Cancer Biology, Oncology +17

Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model

Krassimira Yoncheva, María Merino, Aslihan Shenol et al. · International Journal of Pharmaceutics · 2018 · 83 citations

Pharmacy, Bioengineering, Biomedical Engineering +16

Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

María Merino, Teresa Lozano, Noëlia Casares et al. · Journal of Nanobiotechnology · 2021 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

A new immune-nanoplatform for promoting adaptive antitumor immune response

María Merino, Ana M. Contreras-Sandoval, Noëlia Casares et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 41 citations

Life Sciences, Immunology, Oncology +14